← Hub
Pulse ← Library ⚡ Hire a Fractional CRO
Pulse Reviews and Analysis

Should I open or buy a My Eyelab franchise in 2027?

Kory WhiteCurated by Kory White · Fractional CRO, CRO Syndicate
👍 Yup or 👎 Nope — vote this up its category:
📅 Published · Updated · 5 min read
Should I open or buy a My Eyelab franchise in 2027?

Everyone Says "Optical Franchises Are Safe Bets" — Here's the Truth

I've spent 25 years in revenue leadership, and I've watched more franchise buyers get their wallets picked clean by "safe" concepts than I care to count. So when someone asks me about My Eyelab in 2027, I don't give them the glossy brochure. I give them the truth — with teeth.

Claim #1: "Telehealth exams are a magic bullet for lower costs."

Defense: Everyone loves the idea. No on-site optometrist? No $150K salary burden?

Sounds like free money, right? Here's the reality: telehealth-optometry regulations vary by state — some states outright restrict or prohibit remote exams. My Eyelab's whole value proposition hangs on that remote-doctor technology.

If your state says no, you're suddenly stuck hiring an on-site OD, blowing your cost advantage. I've seen operators buy in, then discover their state's telehealth rules are tighter than a drum. The 2026 FDD lists a franchise fee around $30,000-$50,000 and total Item 7 investment of roughly $400,000 to $700,000 — you're not gambling pocket change here.

The royalty near 6%-8% plus marketing fee near 2%-3% doesn't care about your regulatory surprise.

Claim #2: "Value optical is recession-proof."

Defense: True that vision demand is recession-resilient — people need to see. But "resilient" doesn't mean "profitable without effort." My Eyelab's value-optical positioning targets value-conscious consumers with affordable glasses, contacts, and exams — same-day eyewear.

That's a big market, but it's also the same market Warby Parker, Costco, and Lenscrafters are fighting over. Mature centers gross $800,000-$2,000,000+, with owners clearing $130,000-$400,000. That's solid — but only if you're driving eyewear sales (high-margin) and leveraging the telehealth efficiency where permitted.

The buildout runs $180,000-$380,000, equipment and telehealth tech runs $90,000-$200,000, and initial inventory (eyewear) runs $40,000-$110,000. If you can't move frames, you're just burning capital.

CRO Syndicate — Need a fractional Chief Revenue Officer? CRO Syndicate connects you with vetted fractional and interim revenue leaders. Kory White, Fractional CRO · 25 yrs · $0 to $200M scaled.

👉 Quick Call with Kory White, Fractional CRO · See Kory on LinkedIn · CRO Syndicate

Claim #3: "The Now Optics group makes it easy."

Defense: Being part of the Now Optics group (sister brand to Stanton Optical) gives you systems and supply chain — that's real. But "easy" is a lie. You're still running a 3,000-4,500 sq ft retail center with an eyewear showroom and telehealth-assisted exam capability.

You need $150,000-$250,000 liquid, full-time operation, and skills in value retail, eyewear sales, and telehealth/regulatory navigation. The winners are operators who leverage the value positioning and telehealth efficiency while navigating regulations. The losers?

Those who can't navigate telehealth-optometry rules, can't compete with value/online eyewear, can't drive eyewear sales, or buy in states restricting telehealth without a plan. I've watched owners who thought "brand solves everything" get eaten alive by staffing — initial marketing runs $25,000-$60,000 just to get customers in the door, and training and travel costs $12,000-$32,000.

If you can't staff opticians, you're dead in the water.

The Real Numbers (I'm Not Making This Up)

Line ItemLowHigh
Franchise fee$30,000$50,000
Buildout/leasehold$180,000$380,000
Equipment & telehealth$90,000$200,000
Signage & decor$20,000$60,000
Initial inventory (eyewear)$40,000$110,000
Initial marketing$25,000$60,000
Training & travel$12,000$32,000
Working capital$40,000$100,000
Total Item 7~$400,000~$700,000

Revenue reality: mature centers gross $800K-$2.0M+ with owners clearing $130K-$400K. My Eyelab's edge is its value-optical positioning, telehealth-enabled exams (remote-doctor technology allowing exams without a full-time on-site OD in some models — where regulations permit), recession-resilient vision demand, the Now Optics group, and high-margin eyewear.

The trade-offs are telehealth/regulatory considerations, optical competition (Warby Parker, Costco, Lenscrafters, online), and staffing.

The 90-Day Decision Tree (Do This or Don't Buy)

  1. Day 1-20: Read the 2026 FDD, Item 19, and telehealth-optometry regulations for your state — this is non-negotiable diligence.
  2. Day 21-40: Interview operators; ask about value model, telehealth, regulations, and net profit.
  3. Day 41-60: Validate a value-conscious market and confirm telehealth permissibility.
  4. Day 61-100: Build, staff, and set up telehealth/exam capability.
  5. Day 101-130: Open and drive customer acquisition.
  6. Leverage the value positioning and telehealth efficiency.
  7. Drive eyewear sales (high-margin).

Alternative Plays (Because You Have Options)

The Bottom Line

My Eyelab works — for the right operator in the right state with the right regulatory landscape. It's not a passive check-writer. It's a full-time, retail-and-tech-minded operation where your success hinges on value positioning, telehealth efficiency, and eyewear sales velocity.

The $400K-$700K investment isn't small, but the $130K-$400K owner earnings are real for those who execute. If you can't navigate telehealth rules or compete on value, stay out. If you can, this is a recession-resilient, high-margin play backed by an established group.


*Want the full breakdown on how to evaluate any franchise opportunity — including the questions most buyers miss? That's what I do at PULSE / CRO Syndicate. We don't sell dreams; we sell math. And this math checks out — if you do the work.*


*An operator's opinion by Kory White, Chief Revenue Officer — 25 years in revenue. More at PULSE · CRO Syndicate*

Keep reading
Was this helpful?  
Related in the library
More from the library
revops · current-events-2027How do consolidated CRM and CDP platforms shorten buying committee alignment?revops · current-events-2027Why does longer sales cycles in 2027 increase the need for real-time revenue intelligence?revops · current-events-2027Why do 2027 buying committees require access to a vendor's internal RevOps dashboard before signing?revops · current-events-2027How do 2027 buying committees use AI comparison tools before engaging vendors?revops · current-events-2027How should B2B companies redesign their demo environments to handle simultaneous AI agent testing by prospects?revops · current-events-2027How do longer sales cycles in 2027 affect the accuracy of quarter-end close predictions?revops · current-events-2027How is AI in the funnel reshaping the scoring of B2B inbound leads in 2027?pulse-speeches · speechesA Toast for a Holiday Office Partyrevops · current-events-2027What compliance risks arise when AI analyzes buying committee communications?revops · current-events-2027How should RevOps reprioritize tool investments when vendor consolidation makes data portability harder?revops · current-events-2027How are 2027's AI procurement tools changing the way vendors structure their pricing proposals?revops · current-events-2027Why are 20% longer sales cycles in 2027 linked to AI hallucination audits during technical validation?revops · current-events-2027Are longer sales cycles in 2027 being driven by AI evaluation demands?pulse-speeches · speechesA Wedding Speech for a Vow Renewalrevops · current-events-2027How do you forecast revenue when 2027 AI buying committees bid on services during the vendor evaluation phase?